Veteran industry marketing executive Elyse Lovett has launched a new consulting and marketing agency: Lovett Marketing and Advertising Agency LLC.
Veteran industry marketing executive Elyse Lovett has launched a new consulting and marketing agency: Lovett Marketing and Advertising Agency LLC. Lovett, who has an MBA in marketing and an MS in clinical nutrition, has 15 years of experience in the dietary supplement and food ingredient market, most recently serving as vice president of marketing at Nutrition21, and prior to that, as marketing manager for Kyowa Hakko USA and AarhusKarlshamn (AAK).
The new agency will take a science-based approach to market ingredients and finished products, with a main focus on marketing strategies for the heightened consumer demand that highlights clinically studied, efficacious, and health-first products. A full-service agency, Lovett offers brand strategy and positioning, metrics and analytics, social media and public relations, content and design, website development, as well as advertising planning and media outreach.
“The dietary supplement and functional food and beverage industries are constantly changing. Consumers are currently demanding products that are safe and efficacious with proven results,” says Lovett in a press release. “Gearing marketing campaigns by translating science into consumer-friendly language and creating marketing content that generates qualified leads and sales is key in the industry.” Lovett Marketing and Advertising Agency, LLC goes one step further and measures marketing KPI’s (key performance indicators), which Lovett says “is pivotal to success.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.